Valencia Technologies

Valencia Technologies arose from the discovery that more scientifically verifiable work was being done in acupuncture and that there was a place for neuromodulation to further advance the work. Valencia designed and developed the eCoin (previously referred to as the Subcutaneous Neuromodulation System) for the treatment of major chronic conditions. Its first indication is hypertension. Engineered and designed by Dave Peterson and Chula Thenuwara, the eCoin is unique as a leadless device that is 1/8th the size of the smallest pacemaker-like device on the market. With over a billion people on the planet with hypertension, this device is designed to provide an affordable, non-drug therapy way to reduce blood pressure, thus reducing the risk of cardiovascular disease and stroke in these patients.

Valencia has now produced and tested its device in more than 48 hypertensive people. It is in the middle of a randomized, double-blinded, and controlled clinical trial and the early clinical results show clinically significant improvement in blood pressure. For protection of its technology, it has 20 issued patents with four more allowances Valencia is raising funds for an FDA trial to commercialize the eCoin in the US.

For more information on Valencia and the current offering, please visit our website at www.valenciatechnologies.com